시장보고서
상품코드
1181113

세계의 임상시험용 포장 및 라벨 시장 분석(2023-2033년)

Clinical Trial Packaging and Labelling Market Report 2023-2033

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 239 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 임상시험용 포장·라벨 시장 규모는 2033년까지 6.08%의 CAGR로 성장할 것으로 예측되고 있습니다.

세계의 임상시험용 포장·라벨 시장을 분석했으며, 제품의 개요 및 시장의 기본 구조·최신 상황, 주요 촉진·억제요인, 시장 규모 추산·예측(2023-2033년), 유형별·최종사용자별·재료별 및 지역별·주요 국가의 상세 동향, 주요 기업의 개요, COVID-19의 영향과 회복 시나리오 등의 정보를 정리하여 전해드립니다.

목차

제1장 리포트의 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 시장 기회
  • 신종 코로나바이러스 감염증(COVID-19)의 영향 분석
  • Porter's Five Forces 분석
  • PEST 분석

제4장 임상시험용 포장·라벨 시장 분석 : 유형별

  • 주요 분석 결과
  • 시장 매력 지수 : 유형별
  • 시장 규모 추정·예측 : 유형별
  • 1차 포장
    • 시장 규모 : 지역별(단위 : 100만 달러, 2023-2033년)
    • 시장 점유율 : 지역별(2023년·2033년)
  • 2차 포장

제5장 임상시험용 포장·라벨 시장 분석 : 최종사용자별

  • 주요 분석 결과
  • 시장 매력 지수 : 최종사용자별
  • 시장 규모 추정·예측 : 최종사용자별
  • CRO(임상시험수탁기관)
  • 제약기업
  • 연구

제6장 임상시험용 포장·라벨 시장 분석 : 재료별

  • 주요 분석 결과
  • 시장 매력 지수 : 재료별
  • 시장 규모 추정·예측 : 재료별
  • 플라스틱
  • 종이
  • 금속
  • 기타

제7장 임상시험용 포장·라벨 시장 분석 : 지역별

  • 주요 분석 결과
  • 시장 규모 추정·예측 : 지역별

제8장 북미의 임상시험용 포장·라벨 시장 분석

  • 주요 분석 결과
  • 북미 시장 매력도 지수
  • 북미의 임상시험용 포장·라벨 시장 : 국가별(단위 : 100만 달러, 2023년·2028년·2033년)
  • 시장 규모 추정·예측 : 국가별
  • 시장 규모 추정·예측 : 유형별
  • 시장 규모 추정·예측 : 최종사용자별
  • 시장 규모 추정·예측 : 재료별
  • 미국 시장 분석
  • 캐나다 시장 분석

제9장 유럽의 임상시험용 포장·라벨 시장 분석

  • 주요 분석 결과
  • 유럽 시장 매력도 지수
  • 유럽의 임상시험용 포장·라벨 시장 : 국가별(단위 : 100만 달러, 2023년·2028년·2033년)
  • 시장 규모 추정·예측 : 국가별
  • 시장 규모 추정·예측 : 유형별
  • 시장 규모 추정·예측 : 최종사용자별
  • 시장 규모 추정·예측 : 재료별
  • 독일 시장 분석
  • 프랑스 시장 분석
  • 영국 시장 분석
  • 이탈리아 시장 분석
  • 스페인 시장 분석
  • 기타 유럽 국가의 시장 분석

제10장 아시아태평양의 임상시험용 포장·라벨 시장 분석

  • 주요 분석 결과
  • 아시아태평양 시장 매력도 지수
  • 아시아태평양의 임상시험용 포장·라벨 시장 : 국가별(단위 : 100만 달러, 2023년·2028년·2033년)
  • 시장 규모 추정·예측 : 국가별
  • 시장 규모 추정·예측 : 유형별
  • 시장 규모 추정·예측 : 최종사용자별
  • 시장 규모 추정·예측 : 재료별
  • 중국 시장 분석
  • 일본 시장 분석
  • 인도 시장 분석
  • 호주 시장 분석
  • 한국 시장 분석
  • 기타 아시아태평양 국가의 시장 분석

제11장 라틴아메리카의 임상시험용 포장·라벨 시장 분석

  • 주요 분석 결과
  • 라틴아메리카 시장 매력도 지수
  • 라틴아메리카의 임상시험용 포장·라벨 시장 : 국가별(단위 : 100만 달러, 2023년·2028년·2033년)
  • 시장 규모 추정·예측 : 국가별
  • 시장 규모 추정·예측 : 유형별
  • 시장 규모 추정·예측 : 최종사용자별
  • 시장 규모 추정·예측 : 재료별
  • 브라질 시장 분석
  • 멕시코 시장 분석
  • 기타 라틴아메리카 국가의 시장 분석

제12장 중동·아프리카의 임상시험용 포장·라벨 시장 분석

  • 주요 분석 결과
  • 중동·아프리카 시장 매력도 지수
  • 중동·아프리카의 임상시험용 포장·라벨 시장 : 국가별(단위 : 100만 달러, 2023년·2028년·2033년)
  • 시장 규모 추정·예측 : 국가별
  • 시장 규모 추정·예측 : 유형별
  • 시장 규모 추정·예측 : 최종사용자별
  • 시장 규모 추정·예측 : 재료별
  • 걸프협력회의(GCC) 국가의 시장 분석
  • 남아프리카공화국 시장 분석
  • 기타 중동·아프리카 국가의 시장 분석

제13장 기업 개요

  • 경쟁 구도(2021년)
  • Fisher Clinical Services, Inc.(Thermo Fisher Scientific Inc.의 자회사)
  • Caligor Coghlan
  • Mawdsley-Brooks &Co. Ltd.
  • Sharp Services, LLC
  • CordenPharma International
  • Sentry BioPharma Services, Inc.
  • NextPharma Technologies
  • Clinigen Clinical Supplies Management
  • PCI Pharma Services
  • Korber AG
  • Piramal Enterprises Ltd.
  • WestRock Company
  • Almac Group
  • Xerimis
  • OLIVER
  • Alcami Corporation, Inc.
  • Parexel International Corporation
  • WuXi AppTec

제14장 결론과 제안

KSA 23.01.20

The global Clinical Trial Packaging and Labelling market is projected to grow at a CAGR of 6.08% by 2033.

“The Clinical Trial Packaging and Labelling Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Number of Clinical Trials Along with Rising R&D Investments Driving Market Growth

Pharmaceutical companies are putting a lot of emphasis on environment friendly measures across their entire value chain. The development of environmentally friendly packaging for pharmaceutical items has gained importance in recent years. Scientists have started developing substitute materials to limit the use of plastic throughout the whole supply chain as the need to reduce plastic consumption and lower carbon footprints across industries grows. This includes clinical trial packaging supply chain as well. Hence, suppliers offering clinical trial materials with lesser environmental footprint are likely to be preferred over those who are not very environmentally friendly.

Furthermore, clinical trial packaging and labelling market holds a great potential to flourish in the future as there is a great possibilities of new clinical trials for the development of novel as key players are focusing on introducing new therapies in market. Along with this companies are taking advantage of digital marketing in a meaningful way to spread the awareness regarding their new sustainable packaging.

Packaging Waste Likely to Challenge Market Growth

The laws regarding consistency, storage, packaging, labelling, distribution, and recall of ancillary products have been improved by the FDA and other regulatory bodies. Several economies have their own set of rules, guidelines, & regulations set by their respective regulatory bodies. This has temporarily hit the market negatively. Also, it could lead to inventory wastage of non-compliant users/suppliers. This may hinder the market growth in the forecast period.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the clinical trial packaging and labelling market evolving?
  • What is driving and restraining the clinical trial packaging and labelling market?
  • How will each clinical trial packaging and labelling submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each clinical trial packaging and labelling submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading clinical trial packaging and labelling markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2020 and 2033? What are the implications of clinical trial packaging and labelling projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial packaging and labelling market?
  • Where is the clinical trial packaging and labelling market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial packaging and labelling market today, and over the next 10 years:

  • Our 239-page report provides 118 tables and 148 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial packaging and labelling market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial packaging and labelling prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Type

  • Primary Packaging
  • Secondary Packaging

End User

  • CROs
  • Drug Manufacturing Companies
  • Research Labs

Material

  • Metal
  • Plastic
  • Paper
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • Spain
  • UK
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC Countries
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical trial packaging and labelling Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Alcami Corporation, Inc.
  • Almac Group
  • Caligor Coghlan
  • Clinigen Clinical Supplies Management
  • CordenPharma International
  • Fisher Clinical Services, Inc.
  • Korber AG
  • Mawdsley-Brooks & Co. Ltd.
  • NextPharma Technologies
  • OLIVER
  • Parexel International Corporation
  • Piramal Enterprises Ltd.
  • PCI Pharma Services
  • Sentry BioPharma Services, Inc.
  • Sharp Services, LLC
  • WestRock Company
  • WuXi AppTec
  • Xerimis

Overall world revenue for clinical trial packaging and labelling market, 2023 to 2033 in terms of value the market will surpass US$730 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the clinical trial packaging and labelling market, 2023 to 2033 report help you?

In summary, our 230+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for clinical trial packaging and labelling market, 2023 to 2033 Market, with forecasts for process, upstream, downstream, type and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the clinical trial packaging and labelling Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 18 of the major companies involved in the clinical trial packaging and labelling Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the clinical trial packaging and labelling market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Packaging and Labelling Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
      • 3.2.1.2 Growing Innovations and Technological Advancements
      • 3.2.1.3 Changing Regulatory Scenario
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 No Centralised or Uniform Drug Registration Procedure
      • 3.2.2.2 Stringent Regulatory Scenario
      • 3.2.2.3 High Waste
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Tamper Proof Packaging
      • 3.2.3.2 Environmentally Safe Packaging
      • 3.2.3.3 Opportunities in Biologics and Biosimilars Packaging Materials
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis
    • 3.5.1 Political
    • 3.5.2 Economical
    • 3.5.3 Social
    • 3.5.4 Technological

4 Clinical Trial Packaging and Labelling Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 4.4 Primary Packaging
    • 4.4.1 Market Size by Region, 2023-2033 (US$ mn)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
      • 4.4.2.1 Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 4.5 Secondary Packaging
    • 4.5.1 Market Size by Region, 2023-2033 (US$ mn)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)
      • 4.5.2.1 Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type

5 Clinical Trial Packaging and Labelling Market Analysis by End User

  • 5.1 Key Findings
  • 5.2 End User Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 5.4 CRO's
    • 5.4.1 Market Size by Region, 2023-2033 (US$ mn)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Drug Manufacturing Companies
    • 5.5.1 Market Size by Region, 2023-2033 (US$ mn)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Research Labs
    • 5.6.1 Market Size by Region, 2023-2033 (US$ mn)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trial Packaging and Labelling Market Analysis by Material

  • 6.1 Key Findings
  • 6.2 Material Segment: Market Attractiveness Index
  • 6.3 Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 6.4 Plastic
    • 6.4.1 Market Size by Region, 2023-2033 (US$ mn)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Paper
    • 6.5.1 Market Size by Region, 2023-2033 (US$ mn)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Metal
    • 6.6.1 Market Size by Region, 2023-2033 (US$ mn)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Others
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trial Packaging and Labelling Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Clinical Trial Packaging and Labelling Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Clinical Trial Packaging and Labelling Market Attractiveness Index
  • 8.3 North America Clinical Trial Packaging and Labelling Market by Country, 2023, 2028 & 2033 (US$ mn)
  • 8.4 North America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Country
  • 8.5 North America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 8.5.1 North America Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 8.5.2 North America Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 8.6 North America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 8.7 North America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 8.8 U.S. Clinical Trial Packaging and Labelling Market Analysis
  • 8.9 Canada Clinical Trial Packaging and Labelling Market Analysis

9 Europe Clinical Trial Packaging and Labelling Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Clinical Trial Packaging and Labelling Market Attractiveness Index
  • 9.3 Europe Clinical Trial Packaging and Labelling Market by Country, 2023, 2028 & 2033 (US$ mn)
  • 9.4 Europe Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Country
  • 9.5 Europe Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 9.5.1 Europe Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 9.5.2 Europe Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 9.6 Europe Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 9.7 Europe Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 9.8 Germany Clinical Trial Packaging and Labelling Market Analysis
  • 9.9 France Clinical Trial Packaging and Labelling Market Analysis
  • 9.10 U.K. Clinical Trial Packaging and Labelling Market Analysis
  • 9.11 Italy Clinical Trial Packaging and Labelling Market Analysis
  • 9.12 Spain Clinical Trial Packaging and Labelling Market Analysis
  • 9.13 Rest of Europe Clinical Trial Packaging and Labelling Market Analysis

10 Asia Pacific Clinical Trial Packaging and Labelling Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Clinical Trial Packaging and Labelling Market Attractiveness Index
  • 10.3 Asia Pacific Clinical Trial Packaging and Labelling Market by Country, 2023, 2028 & 2033 (US$ mn)
  • 10.4 Asia Pacific Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 10.5.1 Asia Pacific Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 10.5.2 Asia Pacific Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 10.6 Asia Pacific Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 10.7 Asia Pacific Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 10.8 China Clinical Trial Packaging and Labelling Market Analysis
  • 10.9 Japan Clinical Trial Packaging and Labelling Market Analysis
  • 10.10 India Clinical Trial Packaging and Labelling Market Analysis
  • 10.11 Australia Clinical Trial Packaging and Labelling Market Analysis
  • 10.12 South Korea Clinical Trial Packaging and Labelling Market Analysis
  • 10.13 Rest of Asia Pacific Clinical Trial Packaging and Labelling Market Analysis

11 Latin America Clinical Trial Packaging and Labelling Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Clinical Trial Packaging and Labelling Market Attractiveness Index
  • 11.3 Latin America Clinical Trial Packaging and Labelling Market by Country, 2023, 2028 & 2033 (US$ mn)
  • 11.4 Latin America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Country
  • 11.5 Latin America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 11.5.1 Latin America Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 11.5.2 Latin America Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 11.6 Latin America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 11.7 Latin America Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 11.8 Brazil Clinical Trial Packaging and Labelling Market Analysis
  • 11.9 Mexico Clinical Trial Packaging and Labelling Market Analysis
  • 11.10 Rest of Latin America Clinical Trial Packaging and Labelling Market Analysis

12 MEA Clinical Trial Packaging and Labelling Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Clinical Trial Packaging and Labelling Market Attractiveness Index
  • 12.3 MEA Clinical Trial Packaging and Labelling Market by Country, 2023, 2028 & 2033 (US$ mn)
  • 12.4 MEA Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Country
  • 12.5 MEA Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 12.5.1 MEA Primary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
    • 12.5.2 MEA Secondary Packaging in Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Type
  • 12.6 MEA Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by End User
  • 12.7 MEA Clinical Trial Packaging and Labelling Market Size Estimation and Forecast by Material
  • 12.8 GCC Clinical Trial Packaging and Labelling Market Analysis
  • 12.9 South Africa Clinical Trial Packaging and Labelling Market Analysis
  • 12.10 Rest of MEA Clinical Trial Packaging and Labelling Market Analysis

13 Company Profiles

  • 13.1 Competitive Landscape, 2021
  • 13.2 Fisher Clinical Services, Inc. (Subsidiary of Thermo Fisher Scientific Inc.)
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
      • 13.2.3.1 Revenue, 2017-2021
      • 13.2.3.2 Regional Market Shares, 2021
      • 13.2.3.3 Gross Profit, 2017-2021
    • 13.2.4 Product Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 Caligor Coghlan
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Product Benchmarking
  • 13.4 Mawdsley-Brooks & Co. Ltd.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Product Benchmarking
    • 13.4.4 Strategic Outlook
  • 13.5 Sharp Services, LLC
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Product Benchmarking
    • 13.5.4 Strategic Outlook
  • 13.6 CordenPharma International
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Product Benchmarking
  • 13.7 Sentry BioPharma Services, Inc.
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Product Benchmarking
  • 13.8 NextPharma Technologies
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Product Benchmarking
    • 13.8.4 Strategic Outlook
  • 13.9 Clinigen Clinical Supplies Management
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Product Benchmarking
    • 13.9.4 Strategic Outlook
  • 13.10 PCI Pharma Services
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Benchmarking
    • 13.10.4 Strategic Outlook
  • 13.11 Korber AG
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Product Benchmarking
    • 13.11.4 Strategic Outlook
  • 13.12 Piramal Enterprises Ltd.
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Revenue, 2017-2021
      • 13.12.3.2 Regional Market Shares, 2021 (%)
    • 13.12.4 Product Benchmarking
  • 13.13 WestRock Company
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Revenue, 2017-2021
      • 13.13.3.2 Regional Market Shares, 2021 (%)
    • 13.13.4 Product Benchmarking
    • 13.13.5 Strategic Outlook
  • 13.14 Almac Group
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Product Benchmarking
    • 13.14.4 Strategic Outlook
  • 13.15 Xerimis
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Product Benchmarking
    • 13.15.4 Strategic Outlook
  • 13.16 OLIVER
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Product Benchmarking
  • 13.17 Alcami Corporation, Inc.
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Product Benchmarking
    • 13.17.4 Strategic Outlook
  • 13.18 Parexel International Corporation
    • 13.18.1 Company Snapshot
    • 13.18.2 Company Overview
    • 13.18.3 Product Benchmarking
    • 13.18.4 Strategic Outlook
  • 13.19 WuXi AppTec
    • 13.19.1 Company Snapshot
    • 13.19.2 Company Overview
    • 13.19.3 Financial Analysis
      • 13.19.3.1 Revenue, 2017-2021
      • 13.19.3.2 Regional Market Shares, 2021
      • 13.19.3.3 Gross Profit, 2017-2021
    • 13.19.4 Product Benchmarking

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from
  • 14.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제